ଉଇକିପିଡ଼ିଆ

ଅକ୍ସଫୋର୍ଡ-ଆଷ୍ଟ୍ରାଜେନେକା ଜୋଭିଡ ୧୯ ଟିକା

ଏହା ଏକ କୋଭିଡ-୧୯ ରୋଗର ଟିକା

ଅକ୍ସଫୋର୍ଡ-ଆଷ୍ଟ୍ରାଜେନେକା ଜୋଭିଡ ୧୯ ଟିକା, ବିକ୍ରୟ ନାମ କୋଭିଶିଲ୍ଡ ଏବଂ ଭାକ୍ସେଭ୍ରିଆ, ହେଉଛି ଏକ ଜୋଭିଡ ୧୯ ଟିକା ।[୧] [୧୯] ଜୋଭିଡ ୧୯ ରୋକିବା ପାଇଁ ଏହା ୧୭7 ବର୍ଷରୁ ଅଧିକ ଲୋକଙ୍କଠାରେ ବ୍ୟବହୃତ ହୁଏ|। [୧] ପ୍ରାରମ୍ଭିକ ପରୀକ୍ଷଣରୁ ଜଣାପଡିଛି ଯେ ଏହା ଲକ୍ଷଣାତ୍ମକ ଜୋଭିଡ ୧୯ ଟିକାର ବିପଦକୁ ୬୦-୭୪% ହ୍ରାସ କରିଥାଏ | [୧] ଯୁବକମାନଙ୍କ ପାର୍ଶ୍ୱ ପ୍ରତିକ୍ରିୟା ସମ୍ଭାବନା ହେତୁ କେତେକ ଦେଶ ବୟସ୍କ ବ୍ୟକ୍ତିଙ୍କ ପାଇଁ ଏହାର ବ୍ୟବହାରକୁ ସୀମିତ କରିଛନ୍ତି ।[୨୦] ମାଂସପରଶୀରେ ଇଞ୍ଜେକସନ ଆକାରରେ ୪ରୁ ୧୨ ସପ୍ତାହ ବ୍ୟବଧାନରେ ଏହି ଟିକା ଦିଆଯାଏ [୧]

<span title="International nonproprietary name (INN): <nowiki>Mr. Ibrahem/Oxford–AstraZeneca COVID-19 vaccine</nowiki>">Mr. Ibrahem/Oxford–AstraZeneca COVID-19 vaccine
A vial of COVID-19 vaccine AstraZeneca
Vaccine description
Target SARS-CoV-2
Vaccine type Viral vector
Clinical data
Trade names Vaxzevria,[୧] Covishield[୨]
Other names Verity, AZD1222,[୩]

ChAdOx1 nCoV-19,[୪]

ChAdOx1-S,[୫]

COVID-19 Vaccine AstraZeneca,[୬][୭]

AZD2816[୮]
License data
Pregnancy

category
  • <abbr class="country-name" title="<nowiki>Australia</nowiki>">AU: B2[୫][୬]
Routes of

administration 		Intramuscular
Drug class COVID-19 vaccine[୧]
Legal status
Legal status
  • <abbr class="country-name" title="<nowiki>Australia</nowiki>">AU: S4 (Prescription only) [୫][୯][୧୦]
  • <abbr class="country-name" title="<nowiki>Brazil</nowiki>">BR: Approved [୧୧][୧୨]
  • <abbr class="country-name" title="<nowiki>Canada</nowiki>">CA: Schedule D [୧୩][୧୪][୧୫]
  • <abbr class="country-name" title="<nowiki>United Kingdom</nowiki>">UK: Conditional and temporary authorisation to supply [୭][୧୬]
  • <abbr class="country-name" title="<nowiki>European Union</nowiki>">EU: Conditional marketing authorisation [୧][୧୭]
  • <abbr class="country-name" title="<nowiki>Republic of Korea</nowiki>">KR: Approved[୧୮]
Full list of Oxford–AstraZeneca vaccine authorizations

ଅଧିକାଂଶ ପାର୍ଶ୍ୱ ପ୍ରତିକ୍ରିୟା ସାମାନ୍ୟରୁ ମଧ୍ୟମ ଧରଣରୁ ହୁଏ ଏବଂ କିଛି ଦିନ ମଧ୍ୟରେ ଉପଶମ ହୋଇଯାଏ । [୧] ଉକ୍ତ ପ୍ରତିକ୍ରିୟା ମଧ୍ୟରେ ଇଞ୍ଜେକ୍ସନ୍ ନେବା ସ୍ଥାନରେ ଯନ୍ତ୍ରଣା, ମୁଣ୍ଡବିନ୍ଧା, ଥକ୍କା, ମାଂସପେଶୀ ଯନ୍ତ୍ରଣା ଏବଂ ବାନ୍ତି ହୋଇପାରେ ।[୧] ବିରଳ ପାର୍ଶ୍ୱ ପ୍ରତିକ୍ରିୟାରେ କମ୍ ପ୍ଲାଟେଲେଟ୍, ଫେସିଆଲ୍ ପାଲସି, ରକ୍ତ ଜମାଟ ବାନ୍ଧିବା, ଗୁଲେନ୍-ବାରେ ସିଣ୍ଡ୍ରୋମ, ଆନାଫାଇଲକ୍ସିସ୍ ଏବଂ କ୍ୟାପିଲାରୀ ଲିକ୍ ସିଣ୍ଡ୍ରୋମ ହୋଇପାରେ ।[୧] ଗର୍ଭାବସ୍ଥାରେ ବ୍ୟବହାର କଲେ ନିର୍ଦ୍ଦିଷ୍ଟ କ୍ଷତିର କୌଣସି ପ୍ରମାଣ ନାହିଁ, ଯଦିଓ ଏହିପରି ବ୍ୟବହାରର ଭଲ ଭାବରେ ଅଧ୍ୟୟନ କରାଯାଇ ନାହିଁ ।[୨୧] ଏହା ଏକ ଭାଇରାଲ୍ ଭେକ୍ଟର ଟିକା, ଅର୍ଥାତ୍ ଏହା ଅନ୍ୟ ଏକ ଭୂତାଣୂ ( ଆଡେନୋଭାଇରସ୍ )ଦ୍ୱାରା ଗଠିତ ଜିନ‌କୁ ଏସଏଆଅରଏସ-କୋଭ-୨ ଭୂତାଣୁର ସ୍ପାଇକ ପ୍ରୋଟିନ୍ ତିଆରି ପାଇଁ ପରିବର୍ତ୍ତିତ ହୋଇଛି | [୧]

୩୦ ଡିସେମ୍ବର ୨୦୨୦ରେ ଏହି ଟିକାକୁ ବ୍ରିଟେନରେ ବ୍ୟବହାର ପାଇଁ ଅନୁମୋଦନ କରାଯାଇଥିଲା । [୨୨] ଏହା ପରବର୍ତ୍ତୀ ସମୟରେ ୨୦୨୨ ସୁଦ୍ଧା ଅତି କମରେ ୧୮୨ଟି ଦେଶରେ କିଛି ସ୍ତରରେ ବ୍ୟବହାର ପାଇଁ ଅନୁମତି ପ୍ରାପ୍ତ ହୋଇଛନ୍ତି ।[୨୩] ବିଶ୍ୱ ସ୍ୱାସ୍ଥ୍ୟ ସଂଗଠନଦ୍ୱାରା ଜରୁରୀକାଳୀନ ବ୍ୟବହାର ତାଲିକା ପାଇଁ ଏହାକୁ ଅନୁମୋଦିତ ହୋଇଛି | [୨୪] ବ୍ରିଟେନରେ ଅକ୍ସଫୋର୍ଡ ୟୁନିଭରସିଟି ଏବଂ ବ୍ରିଟିଶ-ସ୍ୱିଡେନ କମ୍ପାନୀ ଆଷ୍ଟ୍ରାଜେନେକାଦ୍ୱାରା ଏହା ବିକଶିତ ହୋଇଥିଲା ।[୨୫] [୨୬] ଜାନୁଆରୀ ୨୦୨୨ ସୁଦ୍ଧା ସାରା ବିଶ୍ୱରେ ୨.୫ ବିଲିୟନରୁ ଅଧିକ ଡୋଜ ଦିଆଯାଇଛି । [୨୫] ଏହାର ଏକ ମାତ୍ରା ପାଇଁ ପ୍ରାୟ ୨ରୁ ୫ ଡଲାର ଖର୍ଚ୍ଚ ହୋଇଥାଏ । [୨୭] ଏହି ଟିକା ରେଫ୍ରିଜରେଟର ତାପମାତ୍ରାରେ ୬ ମାସ ପର୍ଯ୍ୟନ୍ତ ସ୍ଥିର ରହିପାରେ । [୨୮]

  1. ↑ ୧.୦୦ ୧.୦୧ ୧.୦୨ ୧.୦୩ ୧.୦୪ ୧.୦୫ ୧.୦୬ ୧.୦୭ ୧.୦୮ ୧.୦୯ ୧.୧୦ "Vaxzevria (previously COVID-19 Vaccine AstraZeneca) EPAR". European Medicines Agency (EMA). Archived from the original on 21 April 2021. Retrieved 27 March 2021. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
  2. ↑ "Already produced 40–50 million dosages of Covishield vaccine, says Serum Institute". The Hindu. 28 December 2020. Archived from the original on 20 April 2021. Retrieved 30 December 2020.
  3. ↑ "AstraZeneca COVID-19 Vaccine (AZD1222)" (PDF). AstraZeneca. 27 January 2021. Archived (PDF) from the original on 27 January 2021. Retrieved 7 March 2021.
  4. ↑ "AstraZeneca and Oxford University announce landmark agreement for COVID-19 vaccine". AstraZeneca (Press release). 30 April 2020. Archived from the original on 16 November 2020. Retrieved 13 January 2021.
  5. ↑ ୫.୦ ୫.୧ ୫.୨ "COVID-19 Vaccine AstraZeneca PI". Therapeutic Goods Administration (TGA). Archived from the original on 2021-07-31. Retrieved 2022-01-24.
  6. ↑ ୬.୦ ୬.୧ "COVID-19 Vaccine AstraZeneca". Therapeutic Goods Administration (TGA). 16 February 2021. Archived from the original on 18 March 2021. Retrieved 16 February 2021.
  7. ↑ ୭.୦ ୭.୧ "Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca". Medicines and Healthcare products Regulatory Agency (MHRA). 30 December 2020. Archived from the original on 9 March 2021. Retrieved 4 January 2021.
  8. ↑ "First COVID-19 variant vaccine AZD2816 Phase II/III trial participants vaccinated". Astrazeneca. 27 June 2021. Archived from the original on 27 June 2021. Retrieved 24 July 2021.
  9. ↑ "Summary for ARTG Entry: 349072 COVID-19 Vaccine AstraZeneca (ChAdOx1-S) solution for injection multidose vial"[permanent dead link].{{</nowiki>cite web}}</nowiki>: CS1 maint: url-status (link)
  10. ↑ "COVID-19 vaccine: AstraZeneca ChAdOx1-S". Therapeutic Goods Administration (TGA). 27 August 2021. Archived from the original on 23 October 2021. Retrieved 22 October 2021.
  11. ↑ "Brazil grants full approval to Oxford vaccine, orders Sputnik". Brasilia: France 24. Agence France-Presse. 12 March 2021. Archived from the original on 16 March 2021. Retrieved 13 March 2021.
  12. ↑ "Anvisa aprova registro da vacina da Fiocruz/AstraZeneca e de medicamento contra o coronavírus" [Anvisa approves registration of Fiocruz/AstraZeneca vaccine and drug against the coronavirus] (in Portuguese). Federal government of Brazil. Brazilian Health Regulatory Agency. 20 November 2021. Archived from the original on 20 November 2021. Retrieved 20 November 2021.
  13. ↑ "Regulatory Decision Summary - Vaxzevria". Health Canada. Archived from the original on 26 November 2021. Retrieved 26 November 2021.
  14. ↑ "Regulatory Decision Summary – AstraZeneca COVID-19 Vaccine". Health Canada. 26 February 2021. Archived from the original on 11 March 2021. Retrieved 26 February 2021.
  15. ↑ "AstraZeneca COVID-19 Vaccine monograph" (PDF). AstraZeneca. 26 February 2021. Archived (PDF) from the original on 30 March 2021. Retrieved 5 March 2021.
  16. ↑ "Conditions of Authorisation for COVID-19 Vaccine AstraZeneca". Medicines and Healthcare products Regulatory Agency (MHRA). 30 December 2020. Archived from the original on 18 February 2021. Retrieved 4 January 2021.
  17. ↑ "European Commission authorises third safe and effective vaccine against COVID-19". European Commission (Press release). Archived from the original on 10 February 2021. Retrieved 29 January 2021.
  18. ↑ "아스트라제네카社 코로나19 백신 품목허가" [AstraZeneca's Corona 19 vaccine product license]. 식품의약품안전처 (in Korean). 식품의약품안전처. 10 February 2021. Archived from the original on 10 February 2021. Retrieved 10 February 2021.
  19. ↑ "Covishield and Covaxin: What we know about India's Covid-19 vaccines". BBC News. 4 March 2021. Archived from the original on 7 March 2021. Retrieved 8 March 2021.
  20. ↑ "Spain, Belgium and Italy restrict AstraZeneca Covid vaccine to older people". The Guardian. 8 April 2021. Archived from the original on 9 April 2021. Retrieved 11 April 2021.
  21. ↑ Administration, Australian Government Department of Health Therapeutic Goods (16 February 2021). "COVID-19 Vaccine AstraZeneca". Therapeutic Goods Administration (TGA) (in ଇଂରାଜୀ). Archived from the original on 18 March 2021. Retrieved 30 January 2022.
  22. ↑ "Second COVID-19 vaccine authorised by medicines regulator" (Press release). 30 December 2020. Archived from the original on 15 March 2021. Retrieved 6 March 2021.
  23. ↑ Holder, Josh (29 January 2021). "Tracking Coronavirus Vaccinations Around the World". The New York Times. Archived from the original on 22 December 2021. Retrieved 28 January 2022.
  24. ↑ "Coronavirus disease (COVID-19): Vaccines". World Health Organization (WHO). Archived from the original on 18 December 2020. Retrieved 6 March 2021.
  25. ↑ ୨୫.୦ ୨୫.୧ "One year anniversary of UK deploying Oxford-AstraZeneca vaccine". gov.uk. Archived from the original on 4 January 2022. Retrieved 4 January 2022.
  26. ↑ Corum, Jonathan; Zimmer, Carl (17 December 2020). "How the Oxford-AstraZeneca Vaccine Works". The New York Times. Archived from the original on 5 January 2022. Retrieved 30 January 2022.
  27. ↑ Dyer, Owen (29 January 2021). "Covid-19: Countries are learning what others paid for vaccines". BMJ: n281. doi:10.1136/bmj.n281. {{cite journal}}: |access-date= requires |url= (help)
  28. ↑ "Management of COVID-19 vaccine AstraZeneca (ChAdOx1-S) from refrigerator to administration - Vaccination". www.health.nsw.gov.au. Archived from the original on 18 November 2021. Retrieved 30 January 2022.
"https://or.wikipedia.org/w/index.php?title=ଅକ୍ସଫୋର୍ଡ-ଆଷ୍ଟ୍ରାଜେନେକା_ଜୋଭିଡ_୧୯_ଟିକା&oldid=552246"ରୁ ଅଣାଯାଇଅଛି